Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Vion's Triapine enters second phase I combination trial

July 18, 2001

Australian researchers identify new tumor suppressor gene

July 17, 2001

MedImmune evaluates Vitaxin in new clinical trial in colorectal cancer patients

July 17, 2001

Vion awarded SBIR grant to support development of sulfonyl hydrazine prodrugs

July 17, 2001

Significant clinical antileukemic activity demonstrated for signal transduction inhibitor

July 17, 2001

Aventis licenses new solid tumor treatment from Ajinomoto

July 17, 2001

Antisoma enters supply agreement for thioplatin

July 17, 2001

Nontoxic MMP inhibitor from Pharmacia with antitumor activity

July 16, 2001

Exelixis delivers cancer antibody targets to PDL for further development

July 16, 2001

Neutrophil elastase inhibitor prevents cancer metastasis in animal model

July 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...